Found: 45
Select item for more details and to access through your institution.
Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 3, p. 1, doi. 10.1093/ofid/ofae051
- By:
- Publication type:
- Article
Babesiosis Occurrence Among United States Medicare Beneficiaries, Ages 65 and Older, During 2006–2017: Overall and by State and County of Residence.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofaa608
- By:
- Publication type:
- Article
2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S956, doi. 10.1093/ofid/ofz360.2395
- By:
- Publication type:
- Article
2219. Evaluation of Medicare Claims to Assess Burden of Pertussis Disease in Persons Aged ≥65 Years.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S757, doi. 10.1093/ofid/ofz360.1897
- By:
- Publication type:
- Article
Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dabigatran Compared With Rivaroxaban vs Warfarin.
- Published in:
- JAMA Internal Medicine, 2017, v. 177, n. 5, p. 743, doi. 10.1001/jamainternmed.2017.0567
- By:
- Publication type:
- Article
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study.
- Published in:
- BMC Pediatrics, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12887-024-04756-5
- By:
- Publication type:
- Article
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 6, p. 491, doi. 10.1001/jama.2023.28239
- By:
- Publication type:
- Article
Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 1, p. 29, doi. 10.1007/s40267-022-00969-9
- By:
- Publication type:
- Article
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 3, p. 1, doi. 10.1002/pds.5772
- By:
- Publication type:
- Article
Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 2, p. 1, doi. 10.1002/pds.5749
- By:
- Publication type:
- Article
Trends in Erythropoiesis‐stimulating agent use and blood transfusions for chemotherapy‐induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 5, p. 626, doi. 10.1002/pds.5202
- By:
- Publication type:
- Article
Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022.
- Published in:
- American Journal of Public Health, 2024, v. 114, p. S694, doi. 10.2105/AJPH.2024.307729
- By:
- Publication type:
- Article
Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019–2020 Season.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4251, doi. 10.1093/cid/ciaa1727
- By:
- Publication type:
- Article
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 941, doi. 10.1093/cid/ciab125
- By:
- Publication type:
- Article
Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 3, p. 378, doi. 10.1093/cid/ciy100
- By:
- Publication type:
- Article
Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 6, p. 785, doi. 10.1093/cid/ciw854
- By:
- Publication type:
- Article
Healthy User Bias in Comparative Safety Studies for Brand‐Name vs. Generic Products: The Example of Warfarin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1037, doi. 10.1002/cpt.1498
- By:
- Publication type:
- Article
State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2417634, doi. 10.1001/jamanetworkopen.2024.17634
- By:
- Publication type:
- Article
Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population.
- Published in:
- JGIM: Journal of General Internal Medicine, 2022, v. 37, n. 16, p. 4292, doi. 10.1007/s11606-022-07670-7
- By:
- Publication type:
- Article
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
- Published in:
- JGIM: Journal of General Internal Medicine, 2021, v. 36, n. 12, p. 3802, doi. 10.1007/s11606-021-07155-z
- By:
- Publication type:
- Article
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 10, p. 803, doi. 10.1002/phar.4614
- By:
- Publication type:
- Article
A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 8, p. 1077, doi. 10.1002/pds.4807
- By:
- Publication type:
- Article
Zostavax vaccine effectiveness among US elderly using real‐world evidence: Addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 7, p. 993, doi. 10.1002/pds.4801
- By:
- Publication type:
- Article
Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 10, p. 1190, doi. 10.1002/pds.4260
- By:
- Publication type:
- Article
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 9, p. 911, doi. 10.1002/pds.3644
- By:
- Publication type:
- Article
Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 4, p. 465, doi. 10.1111/irv.12552
- By:
- Publication type:
- Article
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Bleeding Events Following Concurrent Use of Warfarin and Oseltamivir by Medicare Beneficiaries.
- Published in:
- Annals of Pharmacotherapy, 2013, v. 47, n. 11, p. 1420, doi. 10.1177/1060028013500940
- By:
- Publication type:
- Article
Risk Factors for COVID-19 Deaths Among Elderly Nursing Home Medicare Beneficiaries in the Prevaccine Period.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins.
- Published in:
- 2020
- By:
- Publication type:
- journal article